HIA
HAE icon

HFM Investment Advisors’s Haemonetics HAE Stock Holding History

HFM Investment Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$600 Buy
+8
New +$514 ﹤0.01% 929
2026
Q1 		– Sell
-3
Closed -$241 – 1253
2025
Q4 		$241 Buy
+3
New +$202 ﹤0.01% 964
2025
Q3 		– Sell
-3
Closed -$224 – 1287
2025
Q2 		$224 Buy
3
+2
+200% +$132 ﹤0.01% 945
2025
Q1 		$64 Buy
+1
New +$68 ﹤0.01% 986

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HFM Investment Advisors's HAE Position: Q2 2026 in Review

HFM Investment Advisors opened a new position in Haemonetics (HAE) in Q2 2026: 8 shares worth $600. The stake represents ﹤0.01% of the portfolio and ranks #929 among its holdings. This is a return to the name: HFM Investment Advisors previously reported a position in HAE as recently as Q4 2025.

HFM Investment Advisors first reported a position in HAE in Q1 2025 and has held it in 4 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • HFM Investment Advisors held 8 shares of Haemonetics worth $600 as of Q2 2026.
  • Haemonetics was a new HFM Investment Advisors position in Q2 2026.
  • Haemonetics made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #929 holding.
  • HFM Investment Advisors first reported a position in Haemonetics in Q1 2025 and has held it in 4 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.